News | November 13, 2021
Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
_256_384.jpg)
In the period April to August 2021, exports stood at Rs 73,469.29 crores compared to Rs 72,275.22 crores for the period April to August 2020 a growth of 1.65 per cent
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology
The funds will be used to buy medicines, enhance oxygen supply and augment the bed capacity in the local and district level hospitals
Subscribe To Our Newsletter & Stay Updated
